简介内容:ML089 (CID-22416235) is an orally available and potent, selective inhibitor of phosphomannose isomerase (PMI), with potential inhibition of other PMI immediate is a membrane-permeable probe for the study of congenital dysglycosylation type Ia (CDG-Ia).